Search result for Future plans
For individuals 60 and older, RSV vaccination is advised by FDA specialists. Future plans
The second of two new vaccines intended for persons 60 and older to avoid serious illness was declared safe and effective for older adults on Wednesday by a Food and Drug Administration advisory panel. The RSV vaccine is still being reviewed by the agency. The FDA commissioner must still provide ...